1. Wallmeier, J, Nielsen, KG, Kuehni, CE, et al. Motile ciliopathies. Nat Rev Dis Primer 2020; 6(1): 77.
Google Scholar | Crossref | Medline2. Halbeisen, FS, Goutaki, M, Spycher, BD, et al. Lung function in patients with primary ciliary dyskinesia: an iPCD Cohort study. Eur Respir J 2018; 52(2).
Google Scholar | Crossref | Medline3. Goutaki, M, Meier, AB, Halbeisen, FS, et al. Clinical manifestations in primary ciliary dyskinesia: systematic review and meta-analysis. Eur Respir J 2016; 48(4): 1081–1095.
Google Scholar | Crossref | Medline4. Roden, L, Görlich, D, Omran, H, et al. A retrospective analysis of the pathogens in the airways of patients with primary ciliary dyskinesia. Respir Med 2019; 156: 69–77.
Google Scholar | Crossref | Medline5. Alanin, MC, Nielsen, KG, von Buchwald, C, et al. A longitudinal study of lung bacterial pathogens in patients with primary ciliary dyskinesia. Clin Microbiol Infect 2015; 21(12): 1093.e1–1097.
Google Scholar | Crossref6. Behan, L, Rubbo, B, Lucas, JS, et al. The patient’s experience of primary ciliary dyskinesia: a systematic review. Qual Life Res 2017; 26(9): 2265–2285.
Google Scholar | Crossref | Medline7. Jain, K, Padley, SPG, Goldstraw, EJ, et al. Primary ciliary dyskinesia in the paediatric population: range and severity of radiological findings in a cohort of patients receiving tertiary care. Clin Radiol 2007; 62(10): 986–993.
Google Scholar | Crossref | Medline8. Cohen-Cymberknoh, M, Simanovsky, N, Hiller, N, et al. Differences in disease expression between primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency. Chest 2014; 145(4): 738–744.
Google Scholar | Crossref | Medline9. Lucas, JS, Carroll, M. Primary ciliary dyskinesia and cystic fibrosis: different diseases require different treatment. Chest 2014; 145(4): 674–676.
Google Scholar | Crossref | Medline10. Wijers, CD, Chmiel, JF, Gaston, BM. Bacterial infections in patients with primary ciliary dyskinesia: Comparison with cystic fibrosis. Chron Respir Dis 2017; 14(4): 392–406.
Google Scholar | SAGE Journals | ISI11. Swenson, CE, Sadikot, RT. Achromobacter respiratory infections. Ann Am Thorac Soc 2015; 12(2): 252–258.
Google Scholar | Crossref | Medline12. Tetart, M, Wallet, F, Kyheng, M, et al. Impact of Achromobacter xylosoxidans isolation on the respiratory function of adult patients with cystic fibrosis. ERJ Open Res 2019; 5(4).
Google Scholar | Crossref | Medline13. Recio, R, Brañas, P, Martínez, MT, et al. Effect of respiratory Achromobacter spp. infection on pulmonary function in patients with cystic fibrosis. J Med Microbiol 2018; 67(7): 952–956.
Google Scholar | Crossref | Medline14. Cools, P, Ho, E, Vranckx, K, et al. Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature. BMC Microbiol 2016; 16(1): 122.
Google Scholar | Crossref | Medline15. Gabrielaite, M, Bartell, JA, Nørskov-Lauritsen, N, et al. Transmission and antibiotic resistance of Achromobacter in cystic fibrosis. J Clin Microbiol 2021; 59(4).
Google Scholar | Crossref | Medline16. Saiman, L, Siegel, JD, LiPuma, JJ, et al. Infection prevention and control guideline for cystic fibrosis: 2013 update. Infect Control Hosp Epidemiol 2014; 35(Suppl 1):S1–S67.
Google Scholar | Crossref | Medline17. Pereira, RHV, Leão, RS, Carvalho-Assef, AP, et al. Patterns of virulence factor expression and antimicrobial resistance in Achromobacter xylosoxidans and Achromobacter ruhlandii isolates from patients with cystic fibrosis. Epidemiol Infect 2017; 145(3): 600–606.
Google Scholar | Crossref | Medline18. Ardura-Garcia, C, Goutaki, M, Carr, SB, et al. Registries and collaborative studies for primary ciliary dyskinesia in Europe. ERJ Open Res 2020; 6(2).
Google Scholar | Crossref19. Johansen, HK, Moskowitz, SM, Ciofu, O, et al. Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients. J Cyst Fibros 2008; 7(5): 391–397.
Google Scholar | Crossref | Medline20. Kerem, E, Conway, S, Elborn, S, Consensus Committee, et al. Standards of care for patients with cystic fibrosis: a European consensus. J Cyst Fibros 2005; 4(1): 7–26.
Google Scholar | Crossref | Medline21. Wang, M, Ridderberg, W, Hansen, CR, et al. Early treatment with inhaled antibiotics postpones next occurrence of Achromobacter in cystic fibrosis. J Cyst Fibros 2013; 12(6): 638–643.
Google Scholar | Crossref | Medline22. Lucas, JS, Barbato, A, Collins, SA, et al. European Respiratory Society guidelines for the diagnosis of primary ciliary dyskinesia. Eur Respir J 2017; 49(1).
Google Scholar | Crossref23. Edwards, BD, Greysson-Wong, J, Somayaji, R, et al. Prevalence and outcomes of Achromobacter species infections in adults with cystic fibrosis: a North American Cohort Study. J Clin Microbiol 2017; 55(7): 2074–2085.
Google Scholar | Crossref | Medline24. Cystic Fibrosis Foundation . Patient Registry 2019 Annual Data Report. Bethesda, Maryland: ©2020 Cystic Fibrosis Foundation, https://www.cff.org/Research/Researcher-Resources/Patient-Registry/2019-Patient-Registry-Annual-Data-Report.pdf
Google Scholar25. Hansen, CR, Pressler, T, Nielsen, KG, et al. Inflammation in Achromobacter xylosoxidans infected cystic fibrosis patients. J Cyst Fibros 2010; 9(1): 51–58.
Google Scholar | Crossref | Medline26. Marthin, JK, Lucas, JS, Boon, M, et al. International BEAT-PCD consensus statement for infection prevention and control for primary ciliary dyskinesia in collaboration with ERN-LUNG PCD Core Network and patient representatives. ERJ Open Res 2021; 7(3).
Google Scholar | Crossref | Medline27. Goutaki, M, Papon, J-F, Boon, M, et al. Standardised clinical data from patients with primary ciliary dyskinesia: FOLLOW-PCD. ERJ Open Res 2020; 6(1).
Google Scholar | Crossref28. Werner, C, Lablans, M, Ataian, M, et al. An international registry for primary ciliary dyskinesia. Eur Respir J 2016; 47(3): 849–859.
Google Scholar | Crossref | Medline